Armes Joseph B 4
4 · CSW INDUSTRIALS, INC. · Filed Mar 24, 2026
Research Summary
AI-generated summary of this filing
CSW Industries (CSW) CEO Joseph Armes Sells 1,500 Shares
What Happened
- Joseph B. Armes, Chairman, President & CEO and a director of CSW Industries, sold 1,500 shares of CSW common stock on March 23, 2026. The weighted-average sale price was $270.11 per share for total proceeds of $405,165. The shares were sold in multiple transactions at prices between $270.00 and $270.50.
Key Details
- Transaction date: 2026-03-23; filing date: 2026-03-24 (timely).
- Type: Sale (code S) — open market or private sale; weighted-average price $270.11; price range $270.00–$270.50.
- Shares owned after transaction: not specified in the provided excerpt.
- Footnote highlights:
- Transaction was effected under a 10b5-1 trading plan established August 12, 2025 (pre-arranged trades).
- Filer can provide a breakdown of how many shares sold at each price within the reported range upon request.
- The filing also lists outstanding performance rights and restricted stock units with various vesting schedules and possible cash-or-stock settlement (see F3–F7).
Context
- Sales executed under a 10b5-1 plan are pre-scheduled and often routine; they do not necessarily indicate the insider’s current view of the company’s prospects.
- The sale was reported promptly (filed the next day), and the multiple transactions were aggregated into a weighted-average price for reporting.
Insider Transaction Report
Form 4
Armes Joseph B
DirectorChairman, President & CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-03-23$270.11/sh−1,500$405,165→ 59,526 total
Holdings
- 3,219(indirect: by ESOP)
Common Stock
- 8,004
Performance Rights
[F3]→ Common Stock (8,004 underlying) - 8,236
Performance Rights
[F4]→ Common Stock (8,236 underlying) - 12,422
Performance Rights
[F5]→ Common Stock (12,422 underlying) - 18,372
Performance Rights
[F6]→ Common Stock (18,372 underlying) - 19,685
Restricted Stock Units
[F7]→ Common Stock (19,685 underlying)
Footnotes (7)
- [F1]The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 12, 2025.
- [F2]The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $270.00 to $270.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2025, and ending on March 31, 2028, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F4]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2024, and ending on March 31, 2027, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F5]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2023, and ending on March 31, 2026, based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F6]Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest in two equal amounts, at a rate between 0% and 200%, during two performance cycles ending on each of March 31, 2026, and 2027 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.
- [F7]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at vesting. 40% of the restricted stock units vest upon the successful recruitment and hiring of a successor Chief Executive Officer; the remaining 60% vest upon the successful first employment anniversary of a successor Chief Executive Officer.
Signature
/s/ Luke E. Alverson, Attorney-in-Fact for Joseph B. Armes|2026-03-24